Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-21Clinical Trial Update: E-Visit for COPD and Smoking Cessation [NA]
A completed clinical trial evaluating an electronic visit (E-Visit) for COPD and smoking cessation, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of GSK3923868 inhalation powder in healthy participants and stable asthma…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Home Pulmonary Rehabilitation for COPD [NA]
A completed clinical trial evaluating home pulmonary rehabilitation for COPD and emphysema has posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Pulmonary and Cardiac Effects of E-Cigarette Use in Pulmonary Patients Who Smoke Cigarettes [Phase 2]
Phase 2 trial update assessing pulmonary and cardiac effects of e-cigarette use in smokers with pulmonary disease; the study has completed r…
-
CLINICAL_TRIALS withdrawal · 2024-02-01Clinical Trial Update: IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the US [Phase 4]
Phase 4 clinical trial IKANOS evaluating Breztri maintenance versus non-triple inhaled therapy after COPD hospitalization has been withdrawn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 bioequivalence study comparing Tiotropium 18 μg inhalation powder in a hard capsule to Spiriva Handihaler 18 μg in COPD patients h…
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation [Phase 3]
Phase 3 clinical trial update investigating eosinophil-driven corticotherapy for patients hospitalized with COPD exacerbation.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Digihaler in Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial update for a Digihaler in chronic obstructive pulmonary disease (COPD) with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) [Phase 2]
Phase 2 clinical trial update on BenRAlizumab for acute exacerbations in asthma and COPD (the ABRA Study).
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Oral Citrulline Supplementation in COPD Patients With Malnutrition [Phase 3]
Phase 3 trial investigating oral citrulline supplementation in COPD patients with malnutrition; status not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial evaluating inhaled nitric oxide for reducing dyspnea and improving exercise tolerance in COPD.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor [Phase 2]
This Clinical Trial Update reports the completion of a Phase 2 study evaluating the safety and efficacy of ivacaftor in chronic obstructive …
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD [Phase 2]
Phase 2 proof-of-concept study evaluating a technology-assisted respiratory adherence prototype in individuals with COPD; study completed wi…
-
FDA approval · 2023-12-19FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the supplemental application for Fluticasone Propionate and Salmeterol from Hikma Pharmaceuticals USA Inc., confirming a supple…
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) [Phase 3]
Phase 3 trial of inhaled treprostinil for pulmonary hypertension due to chronic obstructive pulmonary disease was terminated, with results p…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. [Phase 4]
Phase 4 trial comparing Respimat inhaler to a hydrochlorofluorocarbon metered-dose inhaler (HFA MDI) using Berodual in COPD patients with po…
-
FDA approval · 2023-12-13FDA Approved: INCRUSE ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for INCRUSE ELLIPTA (umeclidinium) submitted by GlaxoSmithKline LLC. This action adds or updates…
-
FDA approval · 2023-12-05FDA Approved: PREDNISONE TABLETS, USP, 5 MG — Supplemental Application (Granulation Technology, Inc.)
FDA granted a supplemental approval for Prednisone Tablets, USP, 5 mg to authorize a granulation technology manufacturing change by Granulat…
-
CLINICAL_TRIALS trial_result · 2023-12-05Clinical Trial Update: 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD) [Phase 4]
Phase 4 trial updating 12-week efficacy of tiotropium versus placebo in mild COPD per Swedish guidelines (SPIRIMILD).
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol. [Phase 3]
Phase 3 trial comparing multiple-dose tiotropium capsules with salmeterol inhalation aerosol in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD [Phase 3]
Phase 3 trial comparing tiotropium inhalation solution (Respimat) with Spiriva HandiHaler in chronic obstructive pulmonary disease, assessin…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients [Phase 3]
Phase 3 trial updating the effects of tiotropium (Spiriva) on exercise tolerance in patients with chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial comparing pharmacokinetics and safety of tiotropium inhalation powder from bromide salt in Hard Capsule via HandiHaler 2 vs Sp…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients. [Phase 4]
A Phase 4 trial comparing tiotropium inhalation capsules to Combivent inhalation aerosol in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Clinical Trial to Investigate the Safety and Tolerability of EP395 in Patients With COPD [Phase 2]
Phase 2 trial investigating safety and tolerability of EP395 in patients with COPD has completed.